Literature DB >> 21050080

Eosinophilic/T-cell chorionic vasculitis: a clinicopathologic and immunohistochemical study of 51 cases.

Suzanne M Jacques1, Faisal Qureshi, Chong Jai Kim, Joon Ho Lee, Tamar Giorgadze, Pooja Mittal, Sonia S Hassan, Roberto Romero.   

Abstract

We report 51 placentas diagnosed with eosinophilic/T-cell chorionic vasculitis (E/TCV), an unusual form of chorionic vasculitis characterized by an infiltrate composed predominantly of CD3+ T cells and eosinophils. The placentas were all 3rd trimester, with 48 (94.1%) being term. Forty-seven (92.2%) were singleton placentas, and the remaining 4 were twins. The E/TCV was limited to 1 chorionic surface vessel in 40 (78.4%) and involved 50% or less of the vessel circumference in 30 (58.8%) placentas. The inflammation faced the intervillous space in 12 (23.5%) and the amniotic cavity in 8 (15.7%) and had no distinct predominant direction in the remaining 31 (60.8%) placentas. Twelve (25.5%) placentas showed mural thrombi or intramural fibrin in association with the E/TCV. One hundred six term singleton placentas were selected as the control group, and the 47 singleton placentas with E/TCV made up the study group for comparison of demographic and histopathologic features. Villitis of unknown etiology was identified more frequently in study group placentas (20 [42.6%]) compared with control group placentas (14 [13.2%]) (P < 0.001). Vascular changes of fetal vascular thrombo-occlusive disease were identified away from the E/TCV more frequently in study group placentas (8 [17.0%]) compared with control group placentas (4 [3.8%]) (P  =  0.008). There were no significant differences in the frequencies of other placental lesions studied, including acute inflammatory lesions and lesions related to maternal underperfusion. There were no significant differences in maternal age, race, parity, birth weight, allergy history, blood type, or medication use.

Entities:  

Mesh:

Year:  2010        PMID: 21050080     DOI: 10.2350/10-07-0867-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  6 in total

1.  A case of recurrent severe pre-eclampsia associated with essential cryofibrinogenaemia.

Authors:  Katrina Chau; Christopher Henderson; Alan Adno; Timothy Spicer; Bruce Cleland; Angela Makris
Journal:  Obstet Med       Date:  2013-05-03

2.  Hypertensive disease, preterm birth, fetal growth restriction and chronic inflammatory disorders of the placenta: experiences in a single institution with a standardized protocol of investigation.

Authors:  Henning Feist; Simin Bajwa; Ulrich Pecks
Journal:  Arch Gynecol Obstet       Date:  2021-10-24       Impact factor: 2.493

3.  The frequency and type of placental histologic lesions in term pregnancies with normal outcome.

Authors:  Roberto Romero; Yeon Mee Kim; Percy Pacora; Chong Jai Kim; Neta Benshalom-Tirosh; Sunil Jaiman; Gaurav Bhatti; Jung-Sun Kim; Faisal Qureshi; Suzanne M Jacques; Eun Jung Jung; Lami Yeo; Bogdan Panaitescu; Eli Maymon; Sonia S Hassan; Chaur-Dong Hsu; Offer Erez
Journal:  J Perinat Med       Date:  2018-08-28       Impact factor: 1.901

4.  Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jezid Miranda; Wonsuk Yoo; Piya Chaemsaithong; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Adi L Tarca; Steven J Korzeniewski; Sonia S Hassan; Nandor Gabor Than; Bo Hyun Yoon; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2013-08       Impact factor: 3.886

Review 5.  Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus.

Authors:  Raymond W Redline; Sanjita Ravishankar; Christina M Bagby; Shahrazad T Saab; Shabnam Zarei
Journal:  Mod Pathol       Date:  2021-02-08       Impact factor: 8.209

Review 6.  Maternal-Fetal Inflammation in the Placenta and the Developmental Origins of Health and Disease.

Authors:  Jeffery A Goldstein; Kelly Gallagher; Celeste Beck; Rajesh Kumar; Alison D Gernand
Journal:  Front Immunol       Date:  2020-11-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.